Icon

XOPENEX HFA (nda021730)- (EQ 0.045MG BASE/INH)

LEVALBUTEROL TARTRATE LUPIN
EQ 0.045MG BASE/INH
Yes Yes
2024-Oct-08 Expired
None None
None No
XOPENEX HFA is a beta2-adrenergic agonist indicated for the treatment or prevention of bronchospasm in patients 4 years of age and older with reversible obstructive airway disease.
0 0 0
Total Other Developers 4
Drugs with Suitability No
EQ 0.045MG BASE/INH ** ** Down - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.